The Biotechnology Industry Organization (BIO) today announces plenary sessions, Business Roundtables and Therapeutic Workshops selected for the 15th annual BIO CEO & Investor Conference. Moderators and panelists chosen to speak represent former White House Chiefs of Staff, industry thought leaders, academics and biopharma executives. The conference, to be held in New York City, February 11 – 12, 2013, is the largest independent investor conference focused on publicly-traded biotechnology companies.